Stockreport

Adagene Expands Scientific and Strategic Advisory Board with Appointment of David Gandara, M.D.

Adagene Inc. - ADS, each representing 1.25 ordinary shares  (ADAG) 
PDF - Dr. Gandara, Professor and Senior Advisor to the Thoracic Oncology Program at University of California Davis, brings deep expertise and strategic vision in cancer drug [Read more]